The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, yet its legacy within the broader market now raises questions about long-term yields . Generic versions are eroding patent protection , causing worries that investing in companies closely tied to Viagra's former standing could be a problematic decision , especially